Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pierre Fabre
Woman and Man Max 99 years
Pierre Fabre Médicament - IRPF
Update Il y a 4 ans
Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder
- To assess the percentage of responders in both treatment groups, Milnacipran or Venlafaxine administered up to 200 mg/day in flexible doses, during a treatment period of 8 weeks including up-titrati...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Effects of OMACOR in patients with a cardiac sodium channel gene SCN5A mutation, one variant of the congenital long-QT syndrome. A proof of concept study
To assess the effect of Omacor on the electrocardiographic QTc Fridericia interval in LQT3 patients (cardiac sodium channel gene SCN5A mutation leading to congenital long-QT syndrome).
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Dermo-Cosmétique
Update Il y a 4 ans
Non inferiority study of a malathion 0.5% lotion versus reference therapy in the treatment of head lice: multicentre, randomised, investigator masked, parallel group
The main objective is to assess the non inferiority of malathion 0.5% lotion (V3777 A) versus Prioderm® lotion (0.5% Malathion), in the cure of the head lice 14 days after two one-hour applications, o...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Comparative study of the effect of 4-week treatment with ossein-hydroxyapatite compound versus calcium carbonate on bone biomarkers in young women with low calcium intake. Prospective, monocenter, randomized, open-label, two-period,cross-over trial
The main objective of this study is to compare the effect of 4-week treatment with ossein-hydroxyapatite compound versus calcium carbonate on biochemical markers of bone resorption in young women with...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
ORAL VINORELBINE AND CISPLATIN WITH CONCOMITANT RADIOTHERAPY FOLLOWED BY EITHER CONSOLIDATION THERAPY WITH ORAL VINORELBINE AND CISPLATIN PLUS BEST SUPPORTIVE CARE OR BEST SUPPORTIVE CARE ALONE IN STAGE III NON SMALL CELL LUNG CANCER (NSCLC): A RANDOMIZED PHASE III STUDY
To compare progression-free survival in both arms.
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Pierre Fabre Dermatologie represented by the Institut de Recherche Pierre Fabre (IRPF)
Update Il y a 4 ans
Assessment of the efficacy of a new formulation of minoxidil (DC120) on hair growth, in a minizone model in androgenetic alopecia in men
To demonstrate the non-inferiority of DC120 on hair growth, versus a reference product (ALOSTIL®), in the treatment of androgenetic alopecia, over 16 weeks.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Etude de l’efficacite de la dihydroergotamine par voie orale dans l’hypotension orthostatique de patients dysautonomiques
Montrer l’effet d’Ikaran® LP 5 mg dans l’hypotension orthostatique de patients dysautonomiques.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Research Institute (France)
Update Il y a 4 ans
Intra-articular hyaluronic acid and chondroitin sulfate in osteoarthritis of the knee
Background and study aims Osteoarthritis is a condition that causes joints to become painful and stiff. In the treatment of osteoarthritis, it is now agreed that surgical procedures should be at least...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Comparative study of efficacy and safety of Structum® and Chondrosulf® in patients with symptomatic osteoarthritis of the knee.A Multicenter, Randomized, Double-Blind, Double Placebo-Controlled, Parallel Group Study
To demonstrate non-inferiority of Structum® to Chondrosulf® on pain relief and functional improvement in patients with symptomatic knee OA over 24 weeks.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Dermo-Cosmétique
Update Il y a 4 ans
Study to evaluate the efficacy and tolerance of a new restorative cream in association with a corticosteroid in adults with Atopic Dermatitis Studie zur Untersuchung der Wirksamkeit und Verträglichkeit einer neuen stärkenden Creme in Kombination mit einem Kortisonpräparat bei Erwachsenen mit Neurodermitis
The primary objective will be to evaluate the benefit of the association of the product RV4421A BS0042 with a moderately potent topical corticosteroid compared with the moderately potent topical corti...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
5
6
Next